CM
HZNP

Crystalline Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Crystalline Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-54,845
Closed -$6.35M – 145
2023
Q3 		$6.35M Buy
54,845
+14,845
+37% +$1.72M 4.56% 4
2023
Q2 		$4.11M Sell
40,000
-10,000
-20% -$1.03M 2.91% 6
2023
Q1 		$5.49M Buy
50,000
+5,000
+11% +$549K 3.99% 7
2022
Q4 		$5.12M Buy
+45,000
New +$5.12M 2.57% 12